Unique stem cell lines identifier | ULLi002-A-49 |
ULLi002-A-51 | |
Institution | University of Louisiana at Lafayette, LA USA |
Contact information of the reported cell line distributor | Baojin Ding (Baojin.Ding@Louisiana.edu) |
Type of cell lines | iPSC |
Origin | Human |
Additional origin info (applicable for human ESC or iPSC) | Age: 30 YR Sex: Male Ethnicity: Asian |
Cell Source | Skin fibroblasts. |
Method of reprogramming | N/A |
Clonality | Clonal |
Evidence of the reprogramming transgene loss (including genomic copy if applicable) | RT/q-PCR |
Cell culture system used | Serum-free and feeder-free medium |
Type of Genetic Modification | Induced mutation |
Associated disease | DYT1 dystonia |
Gene/locus | TOR1A c.907_909delGAG (p.Glu303del)/9q34.11 |
Multiline rationale | Isogenic clones carrying heterozygous or homozygous of the same gene mutation. |
Method of modification/site-specific nuclease used | CRISPR/Cas9 |
Site-specific nuclease (SSN) delivery method | Electroporated with a 4D-Nucleofector (Lonza) using CA-137 program. |
All genetic material introduced into the cells | gRNA vector MLM3636 (Addgene #43860) Cas9 vector p3s-Cas9HC (Addgene #43945) |
Unique stem cell lines identifier | ULLi002-A-49 ULLi002-A-51 |
Analysis of the nuclease-targeted allele status | Sequencing of the targeted allele |
Method of the off-target nuclease activity surveillance | Targeted PCR/sequencing |
Name of transgene | N/A |
Eukaryotic selective agent resistance (including inducible/gene expressing cell-specific) | N/A |
Inducible/constitutive system details | N/A |
Date archived/stock date | 4/29/2021 |
Cell line repository/bank |
https://hpscreg.eu/cell-line/ULLi002-A-49
https://hpscreg.eu/cell-line/ULLi002-A-51 |
Ethical/GMO work approvals | Genetic modification was performed at Genome Engineering and iPSC Center (GEiC) at Washington University in St. Louis. |
Addgene/public access repository recombinant DNA sources’ disclaimers (if applicable) | N/A |